Clinical Convergence™: Patient and Provider Perspectives on Care for Hereditary Angioedema: Follow-up Visit

Allergy/ Immunology
Clinical ConvergenceSM: Patient and Provider Perspectives in HAE
1.25 AMA PRA Category 1 Credit(s)
Launch Date:
March 24, 2016
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Allergy/immunology, dermatology, emergency medicine, and primary care physicians, nurse practitioners, and physician assistants

Relevant Terms:

Hereditary angioedema

Marc Riedl, MD, MS

Marc Riedl, MD, MS
Professor of Medicine
Clinical Director, US HAEA Angioedema Center
University of California, San Diego
San Diego, CA

Marc Riedl, MD, MS, is professor of medicine at the University of California, San Diego (UCSD), and clinical director at the US HAEA Angioedema Center in San Diego, California. He received his medical degree from the University of Chicago–Pritzker School of Medicine, and completed a residency in internal medicine at Barnes-Jewish Hospital of Washington University in St. Louis and a fellowship in clinical immunology and allergy at University of California, Los Angeles (UCLA). Dr. Riedl received a master of science degree in clinical research and completed advanced training in clinical pharmacology at UCLA. He is board certified in internal medicine, clinical pharmacology, and allergy and immunology.
Dr. Riedl's professional interests include angioedema conditions and primary immunodeficiencies. He has published extensively in these areas, serves on numerous editorial boards and scientific committees as well as appointed expert panels for the Food and Drug Administration and National Institutes of Health, and directs an active clinical research program at UCSD.

Aleena Banerji, MD

Aleena Banerji, MD
Assistant Professor
Assistant Training Program Director
Department of Medicine
Allergy and Immunology Unit
Assistant in Medicine
Massachusetts General Hospital
Boston, MA

Aleena Banerji, MD, is an Assistant Professor and Assistant Training Program Director in Allergy and Immunology at Massachusetts General Hospital in Boston, Massachusetts. Dr. Banerji completed her residency in medicine at the University Hospitals of Cleveland/Case Western Reserve in Cleveland, Ohio, where she received the Charles CJ Carpenter Award for Outstanding Performance. She then went on to complete her clinical fellowship in allergy and immunology at Massachusetts General Hospital. She is board-certified in internal medicine and allergy and immunology.
Dr. Banerji's clinical interests include anaphylaxis, angioedema, drug allergy, dermatitis, immunodeficiency, and rhinosinusitis. She has published many peer-reviewed articles on topics including angioedema, atopic disorders, and respiratory disorders. She is currently a primary investigator in a research study evaluating prophylactic treatment for hereditary angioedema.
1. Describe the epidemiology, pathophysiology, and burden of illness of hereditary angioedema (HAE)
2. Recognize HAE as a possible cause of recurrent angioedema and formulate an appropriate diagnostic workup for various types of HAE (Type I, Type II, and normal C1-INH)
3. Utilize individualized HAE treatment strategies, taking into consideration risks and benefits of therapies, disease characteristics and severity, comorbid conditions, patient quality of life, and patient preference

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
  • Marc Riedl, MD, MS, has affiliations with CSL Behring, Dyax, and Shire (Research, Speaker's Bureau, Consulting); BioCryst and Ionis (Research, Consulting); Salix (Speaker's Bureau, Consulting); Pharming (Research); and Arrowhead (Consulting).
  • Aleena Banerji, MD, has no affiliations with commercial interests to disclose.
  • Sherri KramerMD, has no affiliations with commercial interests to disclose.
  • Amy Reeve has no affiliations with commercial interests relative to the content to disclose.
  • Nora Hartley has no affiliations with commercial interests to disclose.
Postgraduate Institute for Medicine
The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Estimated time to complete: 1.25 hours
Medium: Internet

There is no fee for this educational activity.

This activity is supported by an independent medical educational grant from Shire.

By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 1.25 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.
Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
Supported Browsers:
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above